Skip to main content
鹿得医疗 logo

鹿得医疗 — Investor Relations & Filings

Ticker · 920278 Beijing Stock Exchange Manufacturing
Filings indexed 386 across all filing types
Latest filing 2022-03-30 Transaction in Own Shar…
Country CN China
Listing Beijing Stock Exchange 920278

About 鹿得医疗

https://www.asian-medical.com/

Jiangsu Lude Medical Device Co., Ltd. specializes in the research, development, and manufacturing of home medical diagnostic and respiratory care equipment. The company's core product portfolio includes mechanical and electronic sphygmomanometers, stethoscopes, nebulizers, and digital thermometers. It focuses on providing high-precision instruments for chronic disease management and home healthcare. With a strong emphasis on technical innovation and quality control, the firm maintains various international quality certifications to support its global OEM and ODM service capabilities. Its products are designed to meet the needs of both professional medical environments and domestic health monitoring, emphasizing accuracy, reliability, and user-friendly operation in the field of physiological parameter measurement.

Recent filings

Filing Released Lang Actions
回购股份方案公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding a company's share repurchase plan, including the board meeting resolution, purpose, pricing, quantity, funding source, implementation period, impact on financials, and risk factors. It specifically discusses the company's plan to buy back shares for equity incentives, with detailed financial data and regulatory compliance references. This matches the definition of a Transaction in Own Shares (POS) filing, which covers company buyback or issuance of its own shares. The document is not a report or announcement of a report publication, nor is it a regulatory filing or other category. The length and detail confirm it is the actual announcement of the share repurchase plan.
2022-03-30 Chinese
独立董事关于公司第三届董事会第十一次会议相关事项的独立意见
Transaction in Own Shares Classification · 95% confidence The document is an independent directors' opinion on the company's share repurchase plan, including financial data and compliance with regulatory guidelines. It discusses the company's share buyback proposal, financial condition, and confirms no adverse impact on the company. This is a report related to a share repurchase transaction, not a full financial report or announcement of a report. Therefore, it fits the category of Transaction in Own Shares (POS). The document length is short but contains substantive content about the share repurchase plan and independent directors' approval, not merely an announcement or certification.
2022-03-30 Chinese
第三届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 11th meeting of the 3rd Board of Directors of Jiangsu Lude Medical Electronics Co., Ltd. It details the meeting date, attendance, agenda items, and voting results, specifically about a share repurchase plan. It is not a full report but a formal announcement of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short and focused on board resolutions, not financial results or other report types.
2022-03-30 Chinese
关于更换持续督导保荐代表人的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the change of the continuous supervision sponsor representative for the company. It details personnel changes related to the sponsor representatives overseeing the company's stock issuance and listing. There is no financial data, report content, or detailed financial analysis. The document is a formal announcement about management changes related to sponsorship duties, not a full management or board change announcement, but it fits best under Board/Management Information as it concerns key personnel changes in supervisory roles related to the company’s listing and compliance. The document length is short and focused on personnel change, not a report or regulatory filing. Therefore, the classification is MANG (Board/Management Information).
2022-03-06 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the lifting of stock trading restrictions (解除限售公告) for certain shareholders, detailing the number of shares becoming tradable, the shareholders involved, and the reasons for lifting the restrictions. It includes tables showing shareholding details before and after the lifting of restrictions. There is no financial performance data, no discussion of earnings, no management commentary, and no mention of a report being attached or published. The document is a regulatory announcement about share capital status changes related to restricted shares becoming unrestricted and tradable. This fits best under the category of Share Issue/Capital Change (SHA), as it concerns changes in share capital status and tradability rather than a full report or other types of filings.
2022-03-01 Chinese
股票解除限售公告(更正公告)
Share Issue/Capital Change Classification · 95% confidence The document is a correction announcement regarding a previous stock unlocking (解除限售) announcement by Jiangsu Lude Medical Electronics Co., Ltd. It details the corrected number of shares released from lock-up and the updated shareholding structure. The document is short (2422 characters) and focuses on correcting a prior announcement rather than presenting a full financial report or detailed financial data. It is an announcement related to share capital changes, specifically the unlocking of restricted shares, which fits best under the category of Share Issue/Capital Change (SHA).
2022-03-01 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.